[The role of intestinal absorption blockade in hypercholesterolemia treatment].
Diz-Lois
F
F
Departamento de Medicina Interna, Hospital Juan Canalejo, La Coruña. diz-lois@canalejo.org
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D001384:Azetidines / Q000627:therapeutic use*; D002784:Cholesterol / Q000378:metabolism*; D000069438:Ezetimibe; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy*; D007415:Intestinal Obstruction / Q000209:etiology* / Q000378:metabolism*; D011758:Pyrroles / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D001384:Azetidines; D006538:Heptanoic Acids; D011758:Pyrroles; D002784:Cholesterol; D000069059:Atorvastatin; D000069438:Ezetimibe
El papel del bloqueo de la absorción intestinal del colesterol en el tratamiento de la hipercolesterolemia.